Genome & Company to present ADC pipeline at World ADC San Diego

Sep 15, 2026 00:13 (38d ago)

Verifying

Genome & Company will present three ADC pipeline programs at World ADC San Diego.
More than 1,300 participants are expected from pharmaceutical, biotech and research organizations worldwide.
Genome & Company completed licensing deals in 2024 and 2025 and targets annual preclinical licensing.

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.